Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes – randomized controlled trial

    Maagensen, H., Larsen, J. R., Jørgensen, Niklas Rye, Fink-Jensen, Anders & Vilsbøll, Tina, 2021, In: Psychiatry Research. 296, 113670.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    The Gut-Bone Axis in Diabetes

    Maagensen, H., Helsted, M. M., Gasbjerg, Lærke Smidt, Vilsbøll, Tina & Knop, Filip Krag, 2023, In: Current Osteoporosis Reports. 21, p. 21–31 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose

    Maagensen, H., Junker, A. E., Jorgensen, N. R., Gluud, Lise Lotte, Knop, Filip Krag & Vilsbøll, Tina, 2018, In: Journal of Clinical Endocrinology & Metabolism. 103, 5, p. 2042-2049 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Renoprotection with Semaglutide and Liraglutide: Direct or Indirect Effects?

    Mann, J. F., Buse, J., Idorn, T., Leiter, L. A., Pratley, R. E., Rasmussen, S., Vilsbøll, Tina, Wolthers, B. & Perkovic, V., 2019, In: Journal of the American Society of Nephrology. 30, Kidney Week Edition, 1 p., SA-OR082.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  5. Published

    Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials

    Mann, J. F. E., Hansen, T., Idorn, T., Leiter, L. A., Marso, S. P., Rossing, Peter, Seufert, J., Tadayon, S. & Vilsbøll, Tina, 2020, In: The Lancet Diabetes and Endocrinology. 8, 11, p. 880-893 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis

    Mann, J. F. E., Buse, J. B., Idorn, T., Leiter, L. A., Pratley, R. E., Rasmussen, S., Vilsbøll, Tina, Wolthers, B. & Perkovic, V., 2021, In: Diabetes, Obesity and Metabolism. 23, 9, p. 2058-2066 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies

    Marlet, I. R., Ölmestig, J. N. E., Vilsbøll, Tina, Rungby, Jørgen & Kruuse, Christina Rostrup, Jun 2018, In: Basic & Clinical Pharmacology & Toxicology. 122, 6, p. 559-569

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

    Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., Woo, V. C., Hansen, O., Holst, A. G., Pettersson, J., Vilsbøll, Tina & SUSTAIN-6 Investigators, S. I., 10 Nov 2016, In: New England Journal of Medicine. 375, 19, p. 1834-1844 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

    Mathiesen, D. S., Lund, A., Vilsbøll, Tina, Knop, Filip Krag & Bagger, J. I., 2021, In: Frontiers in Endocrinology. 11, 617400.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect

    Mathiesen, D. S., Bagger, J., Hansen, K. B., Junker, A. E., Plamboeck, A., Harring, S., Idorn, T., Hornum, M., Holst, Jens Juul, Jonsson, Anna Elisabet, Hansen, Torben, Vilsbøll, Tina, Lund, Asger Bach & Knop, Filip Krag, 2020, In: Endocrine Connections. 9, 12, p. 1221-1232 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 33056950